Stockholders' Equity | STOCKHOLDERS’ EQUITY Convertible Note Exchange On May 25, 2022, the company gave notice calling for the redemption of all its outstanding 4.00% Convertible Senior Notes due 2024, totaling an aggregate principal amount of $64.0 million. The conversion rate was 66.4178 shares of common stock per $1,000 of principal. From July 1, 2022 through July 8, 2022, all $64.0 million of the 4.00% convertible notes were converted into approximately 4.3 million shares of common stock. During August 2022, the company entered into four privately negotiated exchange agreements with certain noteholders of the 4.125% Convertible Senior Notes due 2022 to exchange approximately $32.6 million aggregate principal amount for approximately 1.2 million shares of the company's common stock. Additionally, on September 1, 2022, approximately $1.7 million aggregate principal amount was settled through a combination of $1.7 million in cash and approximately 15 thousand shares of the company's common stock. Components of stockholders’ equity for the three and nine months ended September 30, 2023 and 2022 are as follows (in thousands): Common Stock Additional Retained Deficit Accumulated Other Treasury Stock Total Non- Total Shares Amount Shares Amount Balance, December 31, 2022 62,101 $ 62 $ 1,110,151 $ (142,417) $ (26,591) 2,805 $ (31,174) $ 910,031 $ 151,035 $ 1,061,066 Net loss — — — (70,324) — — — (70,324) 4,075 (66,249) Cash dividends and distributions declared — — — — — — — — (5,305) (5,305) Other comprehensive loss before reclassification — — — — (12,788) — — (12,788) — (12,788) Amounts reclassified from accumulated other comprehensive loss — — — — 1,701 — — 1,701 — 1,701 Other comprehensive loss, net of tax — — — — (11,087) — — (11,087) — (11,087) Investment in subsidiaries — — — — — — — — 185 185 Stock-based compensation 217 — (5,632) — — — — (5,632) 59 (5,573) Balance, March 31, 2023 62,318 62 1,104,519 (212,741) (37,678) 2,805 (31,174) 822,988 150,049 973,037 Net loss — — — (52,604) — — — (52,604) 4,284 (48,320) Cash dividends and distributions declared — — — — — — — — (6,497) (6,497) Other comprehensive loss before reclassification — — — — 710 — — 710 — 710 Amounts reclassified from accumulated other comprehensive loss — — — — 3,602 — — 3,602 — 3,602 Other comprehensive income, net of tax — — — — 4,312 — — 4,312 — 4,312 Investment in subsidiaries — — — — — — — — 8 8 Stock-based compensation 15 — 3,252 — — — — 3,252 60 3,312 Balance, June 30, 2023 62,333 62 1,107,771 (265,345) (33,366) 2,805 (31,174) 777,948 147,904 925,852 Net income — — — 22,311 — — — 22,311 3,981 26,292 Cash dividends and distributions declared — — — — — — — — (5,663) (5,663) Other comprehensive income (loss) before reclassification — — — — 14,469 — — 14,469 — 14,469 Amounts reclassified from accumulated other comprehensive income (loss) — — — — 10,767 — — 10,767 — 10,767 Other comprehensive income (loss), net of tax — — — — 25,236 — — 25,236 — 25,236 Investment in subsidiary — — — — — — — — 65 65 Stock-based compensation (15) — 2,654 — — — — 2,654 60 2,714 Balance, September 30, 2023 62,318 $ 62 $ 1,110,425 $ (243,034) $ (8,130) 2,805 $ (31,174) $ 828,149 $ 146,347 $ 974,496 Common Stock Additional Retained Deficit Accumulated Other Treasury Stock Total Non- Total Shares Amount Shares Amount Balance, December 31, 2021 61,840 $ 62 $ 1,069,573 $ (15,199) $ (12,310) 8,244 $ (91,626) $ 950,500 $ 151,519 $ 1,102,019 Net income (loss) — — — (61,474) — — — (61,474) 5,602 (55,872) Cash dividends and distributions declared — — — — — — — — (5,122) (5,122) Other comprehensive income (loss) before reclassification — — — — 5,386 — — 5,386 — 5,386 Amounts reclassified from accumulated other comprehensive income (loss) — — — — (1,965) — — (1,965) — (1,965) Other comprehensive income, net of tax — — — — 3,421 — — 3,421 — 3,421 Investment in subsidiaries — — — — — — — — 24 24 Stock-based compensation 226 — (1,922) — — — — (1,922) 59 (1,863) Balance, March 31, 2022 62,066 62 1,067,651 (76,673) (8,889) 8,244 (91,626) 890,525 152,082 1,042,607 Net income — — — 46,398 — — — 46,398 6,322 52,720 Cash dividends and distributions declared — — — — — — — — (8,098) (8,098) Other comprehensive income (loss) before reclassification — — — — (10,535) — — (10,535) — (10,535) Amounts reclassified from accumulated other comprehensive income (loss) — — — — 2,515 — — 2,515 — 2,515 Other comprehensive loss, net of tax — — — — (8,020) — — (8,020) — (8,020) Investment in subsidiaries — — — — — — — — 190 190 Stock-based compensation 21 — 2,270 — — — — 2,270 60 2,330 Balance, June 30, 2022 62,087 62 1,069,921 (30,275) (16,909) 8,244 (91,626) 931,173 150,556 1,081,729 Net income (loss) — — — (73,526) — — — (73,526) 5,623 (67,903) Cash dividends and distributions declared — — — — — — — — (5,247) (5,247) Other comprehensive income (loss) before reclassification — — — — 7,740 — — 7,740 — 7,740 Amounts reclassified from accumulated other comprehensive income (loss) — — — — (1,662) — — (1,662) — (1,662) Other comprehensive income (loss), net of tax — — — — 6,078 — — 6,078 — 6,078 Exchange of 4.125% convertible notes due 2022 — — 19,756 — — (1,188) 13,211 32,967 — 32,967 Redemption of 4.00% convertible notes due 2024 — — 15,797 — — (4,251) 47,241 63,038 — 63,038 Investment in subsidiary — — — — — — — — 199 199 Stock-based compensation 1 — 2,312 — — — — 2,312 61 2,373 Balance, September 30, 2022 62,088 $ 62 $ 1,107,786 $ (103,801) $ (10,831) 2,805 $ (31,174) $ 962,042 $ 151,192 $ 1,113,234 Amounts reclassified from accumulated other comprehensive loss are as follows (in thousands): Three Months Ended Nine Months Ended Statements of 2023 2022 2023 2022 Gains (losses) on cash flow hedges Commodity derivatives $ (917) $ 6,958 $ (2,435) $ 5,219 (1) Commodity derivatives (13,234) (4,760) (18,688) (3,748) (2) Total gains (losses) on cash flow hedges (14,151) 2,198 (21,123) 1,471 (3) Income tax benefit (expense) 3,384 (536) 5,053 (359) (4) Amounts reclassified from accumulated other comprehensive loss $ (10,767) $ 1,662 $ (16,070) $ 1,112 (1) Revenues (2) Costs of goods sold (3) Income (loss) before income taxes and income (loss) from equity method investees (4) Income tax benefit (expense) |